GPC3 CAR-T cell therapy

GPC3-directed CAR-T cell therapy · Essen Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GPC3 CAR-T cell therapy, covering 2025-07-16 to 2025-07-16. Get the full timeline:

Most recent: Clinical Trial Update: Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer [Phase 1, Phase 2]